Equities

Nymox Pharmaceutical Corp

NYMXF:PKC

Nymox Pharmaceutical Corp

Actions
  • Price (USD)0.05
  • Today's Change-0.013 / -20.63%
  • Shares traded28.36k
  • 1 Year change-93.83%
  • Beta8.6538
Data delayed at least 15 minutes, as of Nov 08 2024 20:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Directors & dealings data is unavailable for this security.

Directors & Officers

Click or tap a row for biographies

NameTitleCompensationAgeOfficer since
Paul AverbackChairman of the Board, President, Chief Executive Officer--741995
Patrick DoodyVice President, General Counsel, Director32.87kUSD--2023
David MorseIndependent Director--672006
James RobinsonIndependent Director--882015
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.